Abstract
This cross-sectional study investigated the association between the estimated glomerular filtration rate (eGFR), a measure of chronic kidney disease (CKD), and cognitive impairment. We used data from 6215 Japanese individuals registered in the Suita Study. Cognitive impairment was defined as a Mini-Mental State Examination (MMSE) score of ≤ 26. Logistic regression was used to calculate odds ratios (ORs) and 95% confidence intervals (95% CIs) of cognitive impairment for eGFR 45–59.9 and < 45 mL/min/1.73 m2 (mild and moderate-to-severe eGFR reductions) compared to eGFR ≥ 60 mL/min/1.73 m2 (normal eGFR). The results showed that both mild and moderate-to-severe eGFR reductions were associated with cognitive impairment: ORs (95% CIs) = 1.49 (1.22–1.83) and 2.35 (1.69–3.26), respectively (p-trend < 0.001). Each increment of eGFR by 10 mL/min/1.73m2 was associated with 4.8% lower odds of cognitive impairment. In conclusion, eGFR reduction was associated with cognitive impairment. Managing CKD is essential for preventing cognitive impairment.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Data availability
For ethical and administrative reasons, data cannot be made available.
References
Nakahori N, Sekine M, Yamada M, Tatsuse T, Kido H, Suzuki M. Future projections of the prevalence of dementia in Japan: results from the Toyama Dementia Survey. BMC Geriatr. 2021;21:602.
Montero-Odasso M, Ismail Z, Livingston G. One third of dementia cases can be prevented within the next 25 years by tackling risk factors. The case “for” and “against”. Alzheimers Res Ther. 2020;12:81.
Umebayashi R, Uchida HA, Matsuoka-Uchiyama N, Sugiyama H, Wada J. Prevalence of chronic kidney disease and variation of its risk factors by the Regions in Okayama Prefecture. J Pers Med. 2022;12:97.
Drew DA, Weiner DE, Sarnak MJ. Cognitive impairment in CKD: pathophysiology, management, and prevention. Am J Kidney Dis. 2019;74:782–90.
Deckers K, Camerino I, van Boxtel MP, Verhey FR, Irving K, Brayne C, et al. Dementia risk in renal dysfunction: a systematic review and meta-analysis of prospective studies. Neurology. 2017;88:198–208.
Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53:982–92.
Levey AS, de Jong PE, Coresh J, El Nahas M, Astor BC, Matsushita K, et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int. 2011;80:17–28.
O’Bryant SE, Humphreys JD, Smith GE, Ivnik RJ, Graff-Radford NR, Petersen RC, et al. Detecting dementia with the mini-mental state examination in highly educated individuals. Arch Neurol. 2008;65:963–7.
Sakuma N, Ura C, Miyamae F, Inagaki H, Ito K, Niikawa H, et al. Distribution of Mini-Mental State Examination scores among urban community-dwelling older adults in Japan. Int J Geriatr Psychiatry. 2017;32:718–25.
Shim YS, Yang DW, Kim HJ, Park YH, Kim S. Characteristic differences in the mini-mental state examination used in Asian countries. BMC Neurol. 2017;17:141.
Miwa K, Tanaka M, Okazaki S, Furukado S, Yagita Y, Sakaguchi M, et al. Chronic kidney disease is associated with dementia independent of cerebral small-vessel disease. Neurology. 2014;82:1051–1057.
Sasaki Y, Marioni R, Kasai M, Ishii H, Yamaguchi S, Meguro K. Chronic kidney disease: a risk factor for dementia onset: a population-based study. The Osaki-Tajiri Project. J Am Geriatr Soc. 2011;59:1175–81.
Hiramatsu R, Iwagami M, Nitsch D. Association between chronic kidney disease and incident diagnosis of dementia in England: a cohort study in Clinical Practice Research Datalink. BMJ Open. 2020;10:e033811.
Helmer C, Stengel B, Metzger M, Froissart M, Massy ZA, Tzourio C, et al. Chronic kidney disease, cognitive decline, and incident dementia: the 3C Study. Neurology. 2011;77:2043–51.
O’Hare AM, Walker R, Haneuse S, Crane PK, McCormick WC, Bowen JD, et al. Relationship between longitudinal measures of renal function and onset of dementia in a community cohort of older adults. J Am Geriatr Soc. 2012;60:2215–22.
Nakamura Y, Kabayama M, Godai K, Tseng W, Akasaka H, Yamamoto K, et al. Longitudinal association of hypertension and dyslipidemia with cognitive function in community-dwelling older adults: the SONIC study. Hypertens Res. 2023;46:1829–39.
Qin J, He Z, Wu L, Wang W, Lin Q, Lin Y, Zheng L. Prevalence of mild cognitive impairment in patients with hypertension: a systematic review and meta-analysis. Hypertens Res. 2021;44:1251–60.
Yu Z, Rebholz CM, Wong E, Chen Y, Matsushita K, Coresh J, et al. Association between hypertension and kidney function decline: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Kidney Dis. 2019;74:310–9.
Li H, Zhao S, Wang R, Gao B. The association between cognitive impairment/dementia and albuminuria: a systematic review and meta-analysis. Clin Exp Nephrol. 2022;26:45–53.
Araumi A, Ichikawa K, Konta T, Fujimoto S, Iseki K, Moriyama T, et al. The distribution of eGFR by age in a community-based healthy population: the Japan specific health checkups study (J-SHC study). Clin Exp Nephrol. 2021;25:1303–10.
Acknowledgements
We would like to thank the Suita Medical Association, the Suita City Health Center Staff, and all cohort members.
Funding
This study was supported by the Intramural Research Fund for the cardiovascular diseases of the National Cerebral and Cardiovascular Center (20-4-9), the JH Young Researcher Grant, the Health and Labour Sciences Research Grants of the Ministry of Health, Labour, and Welfare of Japan, AMED (21dk0207053h0001), and the Japan Science and Technology Agency (JPMJPF2018).
Author information
Authors and Affiliations
Contributions
AA drafted the manuscript. AA, HK, CM, MT, YY, YK, MM, YN, RK, and YK were involved in the study design, statistical analysis, revision, and editing.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Ethical approval
The Suita Study protocol was approved by the Institutional Review Board of the National Cerebral and Cardiovascular Center (R21024). We conducted the study per the Declaration of Helsinki. All participants signed their informed consent forms.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
About this article
Cite this article
Arafa, A., Kawachi, H., Matsumoto, C. et al. The association between the estimated glomerular filtration rate and cognitive impairment: the Suita Study. Hypertens Res 47, 672–676 (2024). https://doi.org/10.1038/s41440-023-01476-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41440-023-01476-8
Keywords
This article is cited by
-
Preface-various factors in the management of blood pressure
Hypertension Research (2024)
-
CKD could be a new risk factor of dementia
Hypertension Research (2024)